Durability of complete response after blinatumomab therapy for relapsed/refractory diffuse large B-cell lymphoma.
Andreas ViardotGeorg HessRalf C BargouNicholas J MorleyGiuseppe GrittiMaria-Elisabeth GoebelerKarim IskanderDavid CohanAlicia ZhangJanet FranklinLuke CoylePublished in: Leukemia & lymphoma (2020)